CorePath: A Breast-Specialized Pathology Foundation Model for Core Needle Biopsy Diagnosis and Risk-Controlled Report Generation

• URL: http://arxiv.org/abs/2608.03079v1
• Date: Tue, 04 Aug 2026 03:43:49 GMT
• Title: CorePath: A Breast-Specialized Pathology Foundation Model for Core Needle Biopsy Diagnosis and Risk-Controlled Report Generation
• Abstract summary: CorePath is a breast-specialized multimodal pathology foundation model fine-tuned from PRISM.<n>CorePath consistently outperformed PRISM across cancer detection, invasion assessment, and histological subtyping.
• Score: 19.43990244213587
• License: http://creativecommons.org/licenses/by-nc-nd/4.0/
• Abstract: Breast core needle biopsy (CNB) is central to breast cancer diagnosis yet remains challenging because limited tissue sampling, lesion heterogeneity, and subtle morphologic overlap can obscure subtype distinctions. We developed CorePath, a breast-specialized multimodal pathology foundation model fine-tuned from PRISM using 7901 paired CNB whole-slide images and diagnostic reports from two centers. Evaluated across six CNB cohorts and two public breast pathology benchmarks without task-specific retraining, CorePath consistently outperformed PRISM across cancer detection, invasion assessment, and histological subtyping. It achieved weighted area under the receiver operating characteristic curves (AUCs) of 0.9526-0.9735 for five-class CNB histological subtyping across private centers. On public benchmarks, CorePath outperformed leading pathology foundation models, achieving the highest weighted AUCs of 0.7780 for BCNB invasive carcinoma subtyping, 0.8178 for BRACS lesion stratification, and 0.8252 for BRACS fine-grained classification. In report generation, CorePath reduced the overall non-breast hallucinations from 30.1% to 2.8%, demonstrating improved domain fidelity after breast-specific adaptation. CorePath-CRG further combined conformal subtype-confidence gating with Learn-Then-Test risk control to enable selective report release, subtype-level fallback, and deferral. CorePath-CRG achieved zero non-breast hallucinations among released outputs and showed the strongest overall performance in pathologist-validated LLM-based Evaluation Scores and quantitative report-generation metrics across most centers. These results demonstrate that domain-specialized foundation models with statistical risk control offer a promising approach for accurate breast CNB diagnosis and reliable report generation.

Related papers

• A Pathology Foundation Model for Gastric Cancer with Real-World Validation [47.19073124722865]
  We present GRACE, a Gastric-specific foundation model for Real-world Assessment and Clinical dEcision support.<n> GRACE was developed from multicenter gastric pathology datasets totaling 48,364 primarily HE-stained whole-slide images from 37,493 patients.<n>When calibrated to maintain non-inferior performance to senior pathologists, the AI-assisted workflow could triage 60.7% of atrophy and 82.7% of intestinal metaplasia cases.
  arXiv  Detail & Related papers  (2026-06-03T12:18:06Z)
• TriALS: Triphasic-Aided Liver Lesion Segmentation Benchmark in Non-Contrast CT [49.93685997940356]
  We describe the TriALS challenge for automated liver lesion segmentation under contrast-limited conditions.<n>The top-performing method achieved a mean venous-phase Dice of 0.754, consistent with human-level performance, yet dropped to 0.57 on NCCT.<n>Algorithm performance was most strongly predicted by training data scale and pre-training strategy.
  arXiv  Detail & Related papers  (2026-05-15T19:23:35Z)
• A Breast Vision Pathology Foundation Model for Real-world Clinical Utility [65.57568187389113]
  We present bfBRAVE, a breast-adaptive pathology foundation model developed and evaluated using a total resource of 101,638 breast wholeslide images.<n>BRAVE supported practical roles in the clinical workflow, including safe exclusion of low-risk cases from routine AI-assisted second-review rescue of initially missed positives and prioritization of cases for further assessment.
  arXiv  Detail & Related papers  (2026-05-06T07:44:39Z)
• MorphDistill: Distilling Unified Morphological Knowledge from Pathology Foundation Models for Colorectal Cancer Survival Prediction [3.2844015242965927]
  We propose MorphDistill, a framework that distills complementary knowledge from multiple pathology foundation models into a CRC-specific encoder.<n>In Stage I, a student encoder is trained using dimension-agnostic multi-teacher distillation with supervised contrastive regularization on large-scale colorectal datasets.<n>In Stage II, the encoder extracts patch-level features from whole-slide images, which are aggregated via attention-based multiple instance learning to predict five-year survival.
  arXiv  Detail & Related papers  (2026-04-07T19:21:18Z)
• A deep learning pipeline for PAM50 subtype classification using histopathology images and multi-objective patch selection [0.2958068627971103]
  The PAM50 gene signature is widely recognized as a standard for classifying breast cancer into intrinsic subtypes.<n>In this study, we introduce a novel optimization-driven deep learning framework that aims to reduce reliance on costly molecular assays.<n>Our method jointly optimize patch informativeness, spatial diversity, uncertainty, and patch count by combining the non-dominated sorting genetic algorithm II (NSGA-II) with Monte Carlo dropout-based uncertainty estimation.
  arXiv  Detail & Related papers  (2026-04-02T09:13:24Z)
• GOLDMARK: Governed Outcome-Linked Diagnostic Model Assessment Reference Kit [7.891604152731754]
  Computational biomarkers (CBs) are histo-derived patterns extracted from hematoxylin-eosin (H&E) whole-slide images (WSIs) to predict therapeutic response or prognosis.<n>We introduce GOLDMARK, a standardized benchmarking framework built on a curated TCGA cohort with clinically actionable OncoKB level 1-3 biomarker labels.
  arXiv  Detail & Related papers  (2026-03-21T15:09:06Z)
• Robust Multicentre Detection and Classification of Colorectal Liver Metastases on CT: Application of Foundation Models [11.274035647041762]
  We developed a foundation model-based AI pipeline for patient-level classification and lesion-level detection of CRLM on CT.<n> UMedPT achieved the best performance and was fine-tuned with a head for classification and an FCOS-based head for lesion detection.
  arXiv  Detail & Related papers  (2026-01-12T14:35:29Z)
• Neural Discrete Representation Learning for Sparse-View CBCT Reconstruction: From Algorithm Design to Prospective Multicenter Clinical Evaluation [64.42236775544579]
  Cone beam computed tomography (CBCT)-guided puncture has become an established approach for diagnosing and treating thoracic tumours.<n>DeepPriorCBCT is a three-stage deep learning framework that achieves diagnostic-grade reconstruction using only one-sixth of the conventional radiation dose.
  arXiv  Detail & Related papers  (2025-11-30T12:45:02Z)
• An Explainable Hybrid AI Framework for Enhanced Tuberculosis and Symptom Detection [55.35661671061754]
  Tuberculosis remains a critical global health issue, particularly in resource-limited and remote areas.<n>We propose a framework which enhances disease and symptom detection on chest X-rays by integrating two supervised heads and a self-supervised head.<n>Our model achieves an accuracy of 98.85% for distinguishing between COVID-19, tuberculosis, and normal cases, and a macro-F1 score of 90.09% for multilabel symptom detection.
  arXiv  Detail & Related papers  (2025-10-21T17:18:55Z)
• Transformer Classification of Breast Lesions: The BreastDCEDL_AMBL Benchmark Dataset and 0.92 AUC Baseline [1.9336815376402718]
  This study introduces a transformer-based framework for automated classification of breast lesions in dynamic contrast-enhanced MRI.<n>We implemented a SegFormer architecture that achieved an AUC of 0.92 for lesion-level classification, with 100% sensitivity and 67% specificity at the patient level.<n>Public release of the dataset, models, and evaluation protocols provides the first standardized benchmark for DCE-MRI lesion classification.
  arXiv  Detail & Related papers  (2025-09-30T15:58:02Z)
• A Disease-Centric Vision-Language Foundation Model for Precision Oncology in Kidney Cancer [54.58205672910646]
  RenalCLIP is a visual-language foundation model for characterization, diagnosis and prognosis of renal mass.<n>It achieved better performance and superior generalizability across 10 core tasks spanning the full clinical workflow of kidney cancer.
  arXiv  Detail & Related papers  (2025-08-22T17:48:19Z)
• Exploiting Precision Mapping and Component-Specific Feature Enhancement for Breast Cancer Segmentation and Identification [0.0]
  We propose novel Deep Learning (DL) frameworks for breast lesion segmentation and classification.<n>We introduce a precision mapping mechanism (PMM) for a precision mapping and attention-driven LinkNet (PMAD-LinkNet) segmentation framework.<n>We also introduce a component-specific feature enhancement module (CSFEM) for a component-specific feature-enhanced classifier (CSFEC-Net)
  arXiv  Detail & Related papers  (2024-07-03T06:40:26Z)
• CIMIL-CRC: a clinically-informed multiple instance learning framework for patient-level colorectal cancer molecular subtypes classification from H\&E stained images [42.771819949806655]
  We introduce CIMIL-CRC', a framework that solves the MSI/MSS MIL problem by efficiently combining a pre-trained feature extraction model with principal component analysis (PCA) to aggregate information from all patches. We assessed our CIMIL-CRC method using the average area under the curve (AUC) from a 5-fold cross-validation experimental setup for model development on the TCGA-CRC-DX cohort.
  arXiv  Detail & Related papers  (2024-01-29T12:56:11Z)
• WSSS4LUAD: Grand Challenge on Weakly-supervised Tissue Semantic Segmentation for Lung Adenocarcinoma [51.50991881342181]
  This challenge includes 10,091 patch-level annotations and over 130 million labeled pixels. First place team achieved mIoU of 0.8413 (tumor: 0.8389, stroma: 0.7931, normal: 0.8919)
  arXiv  Detail & Related papers  (2022-04-13T15:27:05Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.